Mucosis’ needle-free nasal spray vaccine for RSV trial starts
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London...